within Pharmacolibrary.Drugs.ATC.A;

model A01AC02
  extends Pharmacokinetic.Models.PK_2C_enteral(
    weight         = 70,
    F              = 0.77,
    Cl             = 2.266666666666667e-06,
    adminDuration  = 600,
    adminMass      = 6 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.00116,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.005833333333333333,
    Tlag           = 9.0,            
    Vdp             = 0.0018700000000000001,
    k12             = 0.085,
    k21             = 0.085
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>A01AC02</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Dexamethasone is a synthetic corticosteroid used for its anti-inflammatory and immunosuppressant effects. It is approved for use in a wide range of conditions including allergic disorders, skin diseases, rheumatic problems, certain cancers, and cerebral edema. It is also used in the management of COVID-19 in specific patient groups and remains a widely used and approved medication in clinical practice.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters from healthy adult volunteers after single oral administration.</p><h4>References</h4><ol><li><p>Czock, D, et al., &amp; Häussler, U (2005). Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids. <i>Clinical pharmacokinetics</i> 44(1) 61–98. DOI:<a href=&quot;https://doi.org/10.2165/00003088-200544010-00003&quot;>10.2165/00003088-200544010-00003</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/15634032/&quot;>https://pubmed.ncbi.nlm.nih.gov/15634032</a></p></li><li><p>Spoorenberg, SM, et al., &amp; van de Garde, EM (2014). Pharmacokinetics of oral vs. intravenous dexamethasone in patients hospitalized with community-acquired pneumonia. <i>British journal of clinical pharmacology</i> 78(1) 78–83. DOI:<a href=&quot;https://doi.org/10.1111/bcp.12295&quot;>10.1111/bcp.12295</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/24400953/&quot;>https://pubmed.ncbi.nlm.nih.gov/24400953</a></p></li><li><p>Jobe, AH, et al., &amp; Jusko, WJ (2020). Pharmacokinetics and Pharmacodynamics of Intramuscular and Oral Betamethasone and Dexamethasone in Reproductive Age Women in India. <i>Clinical and translational science</i> 13(2) 391–399. DOI:<a href=&quot;https://doi.org/10.1111/cts.12724&quot;>10.1111/cts.12724</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/31808984/&quot;>https://pubmed.ncbi.nlm.nih.gov/31808984</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end A01AC02;
